NEI
WST icon

Northwest & Ethical Investments’s West Pharmaceutical WST Stock Holding History

Northwest & Ethical Investments’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$944K Sell
2,630
-2,076
-44% -$635K 0.02% 292
2026
Q1 		$1.18M Sell
4,706
-5,022
-52% -$1.25M 0.03% 295
2025
Q4 		$2.68M Buy
9,728
+334
+4% +$91.4K 0.06% 236
2025
Q3 		$2.46M Hold
9,394
– – 0.06% 241
2025
Q2 		$2.06M Buy
+9,394
New +$2.01M 0.05% 251
2022
Q4 		– Sell
-2,367
Closed -$582K – 430
2022
Q3 		$582K Sell
2,367
-64
-3% -$19.5K 0.02% 341
2022
Q2 		$735K Buy
2,431
+447
+23% +$145K 0.03% 327
2022
Q1 		$815K Sell
1,984
-491
-20% -$192K 0.03% 317
2021
Q4 		$1.16M Buy
2,475
+638
+35% +$275K 0.03% 286
2021
Q3 		$780K Buy
+1,837
New +$774K 0.03% 316
2021
Q1 		– Sell
-8,847
Closed -$2.51M – 436
2020
Q4 		$2.51M Hold
8,847
– – 0.1% 223
2020
Q3 		$2.43M Buy
8,847
+2,767
+46% +$732K 0.11% 219
2020
Q2 		$1.38M Buy
+6,080
New +$1.19M 0.07% 276

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Northwest & Ethical Investments's WST Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its West Pharmaceutical (WST) stake by 44% in Q2 2026, selling an estimated $635K and leaving 2,630 shares worth $944K. The position accounts for 0.02% of the portfolio, ranked #292.

Northwest & Ethical Investments first reported a position in WST in Q2 2020 and has held it in 13 quarters since. The position peaked at $2.68M in Q4 2025. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Northwest & Ethical Investments held 2,630 shares of West Pharmaceutical worth $944K as of Q2 2026.
  • Northwest & Ethical Investments sold 2,076 West Pharmaceutical shares in Q2 2026, an estimated $635K.
  • West Pharmaceutical made up 0.02% of Northwest & Ethical Investments's portfolio in Q2 2026, its #292 holding.
  • Northwest & Ethical Investments first reported a position in West Pharmaceutical in Q2 2020 and has held it in 13 quarters since.
  • Northwest & Ethical Investments's West Pharmaceutical position peaked at $2.68M in Q4 2025.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.